MKL

Markel Group Inc

Add to Watchlist

Advanced Chart

1908.930

-1.49(-0.078%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

1916.870

Open

1916.390

VWAP

1.91K

Vol

21.37K

Mkt Cap

24.17B

Low

1898.800

Amount

40.82M

EV/EBITDA(TTM)

12.16

Total Shares

13.00M

25.36B

EV/OCF(TTM)

11.20

P/S(TTM)

1.64

Markel Group Inc. is a holding company comprised of various businesses and investments. The Company’s segments include Insurance, Reinsurance, Investing, and Markel Ventures. The Insurance segment includes all direct business written on a risk-bearing basis within the Company's underwriting operations. Its insurance operations include underwriting, program services and other fronting, and Insurance-linked securities. The Reinsurance segment includes all treaty reinsurance written on a risk-bearing basis within the Company's underwriting operations. Its Reinsurance segment product offerings are underwritten primarily by its Global Reinsurance division, which operates from platforms in the United States, Bermuda and United Kingdom. Its Investing segment includes all investing activities related to the Company's insurance operations. The Markel Ventures segment primarily consists of controlling interests in a diverse portfolio of businesses that operate in various industries.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

3.69B

+8.7%

24.350

+2.99%

3.84B

-0.12%

22.700

-2.1%

3.80B

-17.56%

23.670

+13.13%

Estimates Revision

The market is revising Upward the revenue expectations for Markel Group Inc. (MKL) for FY2025, with the revenue forecasts being adjusted by 2.28% over the past three months. During the same period, the stock price has changed by -0.51%.

Revenue Estimates for FY2025

Revise Upward

+2.28%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-3.48%

In Past 3 Month

Stock Price

Go Down

-0.51%

In Past 3 Month

3 Analyst Rating

0.48% Upside

Wall Street analysts forecast MKL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MKL is 1918 USD with a low forecast of 1836 USD and a high forecast of 2000 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

0.48% Upside

Current: 1908.930

Low

1836

Averages

1918

High

2000

0.48% Upside

Current: 1908.930

Low

1836

Averages

1918

High

2000

Argus

Hold

Buy

upgrade

2025-05-30

Reason

Argus

Price Target

2025-05-30

upgrade

Hold

Buy

Reason

Argus upgraded Markel to Buy from Hold.

Argus

downgrade

2025-05-30

Reason

Argus

Price Target

2025-05-30

downgrade

Reason

Argus says that based on Markel's Q1 catastrophe events and projected lower equity valuations, offset by improving investment income, the firm is lowering its GAAP 2025 and 2026 EPS estimates. The company's results and ROE measures are "too inconsistent for us to recommend the shares," though it likes the company's focus on underwriting profitability and accretive acquisitions and "may look to move MKL back to our BUY list" if ROE consistently improves or the company begins to pay a dividend, the analyst tells investors.

RBC Capital

Scott Heleniak

Hold

Maintains

$1,750 → $2,025

2025-02-07

Reason

RBC Capital

Scott Heleniak

Price Target

$1,750 → $2,025

2025-02-07

Maintains

Hold

Reason

TD Cowen

Andrew Kligerman

Strong Buy

Hold

Downgrades

$1,986 → $1,836

2024-12-02

Reason

TD Cowen

Andrew Kligerman

Price Target

$1,986 → $1,836

2024-12-02

Downgrades

Strong Buy

Hold

Reason

TD Cowen analyst Andrew Kligerman downgraded Markel to Hold from Buy with a price target of $1,836, down from $1,986.

RBC Capital

Scott Heleniak

Hold

Maintains

$1,700 → $1,675

2024-11-01

Reason

RBC Capital

Scott Heleniak

Price Target

$1,700 → $1,675

2024-11-01

Maintains

Hold

Reason

RBC Capital lowered the firm's price target on Markel to $1,675 from $1,700 and keeps a Sector Perform rating on the shares. The company's Q3 results were a bit mixed as healthy reserve releases were partly offset by a core loss ratio that remains a bit elevated, while its catastrophe losses were also higher than modeled due to Hurricane Helene impacts, the analyst tells investors in a research note.

Jefferies

Andrew Andersen

Hold

Maintains

$1,590 → $1,600

2024-10-09

Reason

Jefferies

Andrew Andersen

Price Target

$1,590 → $1,600

2024-10-09

Maintains

Hold

Reason

Jefferies raised the firm's price target on Markel to $1,600 from $1,590 and keeps a Hold rating on the shares. Q3 results, particularly for reinsurers, may be overshadowed by this week's Hurricane Milton, says the analyst, who remains most constructive on Personal on improving margins and policies-in-force. For Q3, the analyst expects catastrophe losses below the five-year seasonal average, but "well above 3Q23," with potential downside for primary insurers, the analyst tells investors in a preview for the P&C Insurance/Insurtech group.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Markel Group Inc (MKL.N) is 19.18, compared to its 5-year average forward P/E of 18.02. For a more detailed relative valuation and DCF analysis to assess Markel Group Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

18.02

Current PE

19.18

Overvalued PE

20.26

Undervalued PE

15.79

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

1.37

Current PS

1.57

Overvalued PS

1.52

Undervalued PS

1.22